AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,085,027 | -42.5% | 170,067 | 0.0% | 0.01% | -42.9% |
| Q2 2023 | $1,886,043 | -21.5% | 170,067 | 0.0% | 0.01% | -17.6% |
| Q1 2023 | $2,402,806 | -48.7% | 170,067 | -19.4% | 0.02% | -46.9% |
| Q4 2022 | $4,683,357 | +35.9% | 211,067 | 0.0% | 0.03% | +33.3% |
| Q3 2022 | $3,447,000 | +12.4% | 211,067 | 0.0% | 0.02% | -4.0% |
| Q2 2022 | $3,067,000 | +3.8% | 211,067 | +31.9% | 0.02% | +25.0% |
| Q1 2022 | $2,955,000 | -22.3% | 159,988 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $3,803,000 | -2.6% | 159,988 | +0.9% | 0.02% | -11.1% |
| Q3 2021 | $3,906,000 | -1.2% | 158,588 | -0.9% | 0.03% | 0.0% |
| Q2 2021 | $3,953,000 | +727.0% | 159,988 | +720.6% | 0.03% | +575.0% |
| Q1 2021 | $478,000 | -4.0% | 19,497 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $498,000 | -11.5% | 19,497 | -2.5% | 0.00% | -20.0% |
| Q3 2020 | $563,000 | -0.4% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $565,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |